CD79A and nasopharyngeal carcinoma: Previous study found that IgA-specific antibody against gp350 was evaluated close to the time of NPC diagnosis using a luciferase immunoprecipitation (LIPS) assay, but no difference was observed in the total gp350 antibody level (11).